Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
As of close of business last night, Aurinia Pharmaceuticals Inc’s stock clocked out at $4.87, down -3.18% from its previous closing price of $5.03. In other words, the price has decreased by -$3.18 from its previous closing price. On the day, 1.53 million shares were traded. AUPH stock price reached its highest trading level at $5.01 during the session, while it also had its lowest trading level at $4.77.
Ratios:
To gain a deeper understanding of AUPH’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.99 and its Current Ratio is at 5.50. In the meantime, Its Debt-to-Equity ratio is 0.26 whereas as Long-Term Debt/Eq ratio is at 0.22.
Oppenheimer Upgraded its Perform to Outperform on December 10, 2021, whereas the target price for the stock was revised from $33 to $31.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 06 ’24 when Greenleaf Peter sold 126,981 shares for $5.60 per share. The transaction valued at 711,094 led to the insider holds 1,522,114 shares of the business.
Robertson Stephen P. sold 57,745 shares of AUPH for $323,372 on Mar 06 ’24. The EVP, General Counsel now owns 443,824 shares after completing the transaction at $5.60 per share. On Mar 06 ’24, another insider, Donley Matthew Maxwell, who serves as the EVP, Ops & Strategy of the company, sold 40,665 shares for $5.51 each. As a result, the insider received 224,064 and left with 584,072 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AUPH now has a Market Capitalization of 727426944 and an Enterprise Value of 451526496. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.01 while its Price-to-Book (P/B) ratio in mrq is 1.85. Its current Enterprise Value per Revenue stands at 2.573 whereas that against EBITDA is -6.09.
Stock Price History:
Over the past 52 weeks, AUPH has reached a high of $12.43, while it has fallen to a 52-week low of $4.71. The 50-Day Moving Average of the stock is -9.95%, while the 200-Day Moving Average is calculated to be -38.69%.
Shares Statistics:
It appears that AUPH traded 2.07M shares on average per day over the past three months and 1314310 shares per day over the past ten days. A total of 143.83M shares are outstanding, with a floating share count of 127.86M. Insiders hold about 11.59% of the company’s shares, while institutions hold 36.04% stake in the company. Shares short for AUPH as of 1713139200 were 11392512 with a Short Ratio of 5.50, compared to 1710460800 on 10646836. Therefore, it implies a Short% of Shares Outstanding of 11392512 and a Short% of Float of 7.9.
